43.51
price down icon1.23%   -0.54
after-market Handel nachbörslich: 43.51
loading

Finanzdaten der Kymera Therapeutics Inc-Aktie (KYMR)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
78.52%
10.29
47.88 4.728 16.51 9.466
Operating Expenses
1.37%
68.12
67.20 62.24 59.90 54.79
Benefits Costs and Expenses
73.91%
58.84
225.55 - - 50.39
Costs And Expenses
21.01%
58.84
48.63 62.24 59.90 50.39
Operating Income/Loss
199.46%
-57.83
-19.31 -57.51 -43.38 -45.33
Income/Loss From Continuing Operations Before Tax
72.67%
-48.56
-177.67 4.728 16.51 -40.93
Income/Loss From Continuing Operations After Tax
237.95%
-48.56
-14.37 -52.87 -38.80 -40.93
Net Income/Loss
237.95%
-48.56
-14.37 -52.87 -38.80 -40.93
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
134.22K%
70.77
0.0527 58.42 58.33 58.19
Diluted Average Shares
134.22K%
70.77
0.0527 58.42 58.33 58.19
Basic Earnings Per Share
176.00%
-0.69
-0.25 -0.90 -0.67 -0.70
Diluted Earnings Per Share
176.00%
-0.69
-0.25 -0.90 -0.67 -0.70
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
Kapitalisierung:     |  Volumen (24h):